Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma Progression”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Large-scale testing (Phase 3)Study completedNCT01109004
What this trial is testing

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 758
Early research (Phase 1)UnknownNCT03706547
What this trial is testing

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma Progression
Peng Liu 20
Testing effectiveness (Phase 2)Study completedNCT00908232
What this trial is testing

Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 163
Not applicableLooking for participantsNCT03689595
What this trial is testing

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 30,000
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Not applicableEnded earlyNCT01794572
What this trial is testing

Phase 1-2 Study of Total Bone Marrow Irradiation With Helicoidal Tomotherapy in 1st Myeloma Relapse

Who this might be right for
Multiple Myeloma in Relapse
Institut Cancerologie de l'Ouest 13
Early research (Phase 1)Study completedNCT02189343
What this trial is testing

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT02415413
What this trial is testing

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
PETHEMA Foundation 90
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Very early researchLooking for participantsNCT06209606
What this trial is testing

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncotherapeutics 30
Large-scale testing (Phase 3)Study completedNCT00480363
What this trial is testing

QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 120
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Not applicableLooking for participantsNCT06644625
What this trial is testing

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Who this might be right for
Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more
Wake Forest University Health Sciences 1,665
Early research (Phase 1)UnknownNCT03672253
What this trial is testing

CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma Progression
Second Affiliated Hospital of Xi'an Jiaotong University 20
Not applicableStudy completedNCT01958528
What this trial is testing

Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM

Who this might be right for
a Diagnosis of MGUS or SMM by IMWG Criteria
Abramson Cancer Center at Penn Medicine 52
Testing effectiveness (Phase 2)Ended earlyNCT01116128
What this trial is testing

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Who this might be right for
Myeloma
Fondazione EMN Italy Onlus 8
Testing effectiveness (Phase 2)WithdrawnNCT04150692
What this trial is testing

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT01463670
What this trial is testing

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Load More Results